startup-icon Start-up

CimCure

De Boelelaan 108
1081 HV Amsterdam
Netherlands

Phone

cimcure.com

About CimCure

CimCure is a 2016 spin-off from Amsterdam UMC. CimCure focuses on the design and development of a novel class of active cancer immunotherapies. The company develops cancer vaccines through its proprietary Immune-Boost (iBoost) technology of targeted conjugate vaccines. They have identified specific targets in tumor vasculature. The company is privately funded.

Product portfolio of CimCure

Here you will find CimCure